| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9813 |
| Human Intestinal Absorption | HIA+ | 0.9949 |
| Caco-2 Permeability | Caco2- | 0.5183 |
| P-glycoprotein Substrate | Non-substrate | 0.8630 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9316 |
| Non-inhibitor | 1.0000 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9000 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8425 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6985 |
| CYP450 2D6 Substrate | Non-substrate | 0.8499 |
| CYP450 3A4 Substrate | Non-substrate | 0.6450 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6590 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8175 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9086 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7960 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8294 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9693 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8314 |
| Non-inhibitor | 0.9675 |
| AMES Toxicity | Non AMES toxic | 0.9132 |
| Carcinogens | Non-carcinogens | 0.8871 |
| Fish Toxicity | High FHMT | 0.8783 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9421 |
| Honey Bee Toxicity | Low HBT | 0.8407 |
| Biodegradation | Not ready biodegradable | 0.7808 |
| Acute Oral Toxicity | II | 0.7444 |
| Carcinogenicity (Three-class) | Non-required | 0.6129 |